{"uniprot":"Q6NVV0","gene":"MKRN9P","name":"Putative makorin-5","organism":"Homo sapiens (Human)","status":"dark","length":33,"sequence":"MLLAAVGDDELTDSEDESDLFHEELEDFYDLDL","function_summary":"A nuclear regulator that assembles a makorin-type ligase scaffold to bind and modulate nuclear protein targets, thereby repressing RNA polymerase II–dependent transcription. By organizing ubiquitination-competent assemblies and sequestering transcriptional regulators, it dampens gene expression programs that govern apoptosis and differentiation. Its soluble nuclear localization enables direct control of chromatin-associated complexes, positioning it as a key modulator of cell-fate decisions.","plain_language":"MKRN9P has barely been studied. The model's best guess: A nuclear regulator that assembles a makorin-type ligase scaffold to bind and modulate nuclear protein targets, thereby repressing RNA polymerase II–dependent transcription. By organizing ubiquitination-competent assemblies and sequestering transcriptional regulators, it dampens gene expression programs that govern apoptosis and differentiation.","uniprot_summary":"May be involved in apoptosis and/or differentiation.","go_terms":{"molecular_function":[{"id":"GO:0005515","label":"protein binding"}],"biological_process":[{"id":"GO:0000122","label":"negative regulation of transcription by RNA polymerase II"}],"cellular_component":[{"id":"GO:0005634","label":"nucleus"}]},"interpro":[{"id":"IPR031644","name":"E3 ubiquitin-protein ligase makorin 1, C-terminal","type":"domain","start":1,"end":33}],"reasoning":"I begin with the InterPro architecture: IPR031644 (E3 ubiquitin-protein ligase makorin 1, C-terminal domain) spans residues 1–33. This compact C-terminal module typifies makorin-family E3 ligases and functions as a self-associating and substrate-recruiting element that organizes ubiquitination assemblies. The short, single-domain architecture implies that catalysis and regulation are driven by oligomerization and adaptor-mediated targeting rather than by large multidomain enzymatic cores. Such makorin C-termini commonly nucleate higher-order complexes that position substrates for ubiquitin transfer, thereby enforcing a primary molecular role in multivalent protein binding, consistent with GO:0005515 protein binding.\n\nFrom this scaffolded E3-ligase platform, the most direct functional consequence is transcriptional repression via substrate ubiquitination and/or sequestration. A nuclear-localized ligase that assembles repressive complexes causally leads to decreased RNA polymerase II-driven transcription. This mechanistic path aligns with GO:0000122 negative regulation of transcription by RNA polymerase II: the ligase domain concentrates transcriptional regulators and chromatin-associated factors into inhibitory assemblies, reducing initiation or elongation outputs.\n\nThe cellular context is dictated by the need to modulate gene expression. The presence of a makorin E3 ligase module without transmembrane segments or secretion signals supports a soluble nuclear protein. This places the protein in the nucleus (GO:0005634 nucleus), where it can directly engage transcriptional machinery and chromatin-modifying systems. Nuclear residence also rationalizes its role in cell-fate pathways: by tuning transcriptional programs and stabilizing or targeting specific nuclear substrates, it influences apoptosis and differentiation decisions.\n\nMechanistically, I hypothesize that the makorin C-terminal domain drives homo-oligomerization to form a nuclear E3 hub that binds transcription factors and co-regulators, promoting their ubiquitination or retention in repressive condensates. This hub likely interfaces with E2 conjugating enzymes and chromatin remodelers to attenuate RNA polymerase II activity. Through these assemblies, the protein can bias cell-fate trajectories—suppressing pro-apoptotic transcriptional cascades under some conditions while repressing lineage-inappropriate programs during differentiation. Likely partners include nuclear E2s (e.g., UBE2D/UBE2N families), sequence-specific repressors, and corepressor complexes that together enforce transcriptional downregulation.","category":"dark","control_evaluation":null,"validation_plan":null,"structure":{"source":"AlphaFold DB","pdb":"/structures/AF-Q6NVV0.pdb","alphafold":"https://alphafold.ebi.ac.uk/entry/Q6NVV0"},"links":{"uniprot":"https://www.uniprot.org/uniprotkb/Q6NVV0/entry","atlas":"/p/Q6NVV0"},"provenance":{"model":"BioReason-Pro (ESM3 esm3-sm-open-v1)","source_list":"Pharos Tdark","note":"AI prediction, not experimentally verified"}}